Health care reform legislation: Momentous implications for shaping pharmacy's future

Abstract

AphA–AppM Anyone who travels has heard or asked this question along the way. Are we there yet? The question implies that one is moving forward, is engaged in the process, and is a little impatient for the destination. Does this sound like our experiences with health care reform (HCR)? Many milestones have occurred in the journey toward the landmark HCR legislation. Most notable for pharmacists was the Pharmacy Principles for Health Care Reform1 document, which was supported by major pharmacy organizations and stakeholders. We reached a consensus among a large and diverse group of pharmacy stakeholders and rallied all pharmacists in support of a set of cardinal principles that included (1) quality and safety, (2) infrastructure to support access to medications and pharmacy services, and (3) interoperable health information technology accessible by pharmacists. We worked together to effectively interact with legislators through the many iterations of the bills in the House of Representatives and Senate. We collaborated, we focused our issues, and we were proactive. Promising opportunities exist for pharmacy in the HCR legislation that was passed, including those afThese may include pharmacy-related services such as “conducting comprehensive medication review and management including, if appropriate, counseling and self-management support.” In Section 3201, medication therapy management (MTM), which is envisioned in terms more extensive than those required under Medicare Part D, will support care coordination and management performance bonuses for Medicare Advantage plans. Pharmacists are included explicitly in the health care workforce in Section 5101, which establishes a National Health Care Workforce Commission. These and other opportunities in PPACA will support quality improvement strategies, prevention and wellness initiatives, and workforce programs.